EMILY FERRARA: Open Payments
NPI 1629661376 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,595 in 66 payments from 22 companies in 2025. Trend: 2023 $3,031 · 2024 $4,294 · 2025 $1,595
Food & beverage: $1,359Education: $236
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $332 |
| Janssen Biotech, Inc. | 8 | $240 |
| SOBI, INC | 2 | $139 |
| Celgene Corporation | 6 | $113 |
| Daiichi Sankyo Inc. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 2 | $65 |
| Genentech USA, Inc. | 3 | $64 |
| Incyte Corporation | 3 | $63 |
| ABBVIE INC. | 3 | $59 |
| GENZYME CORPORATION | 2 | $52 |
Products named: SCEMBLIX, DARZALEX, Fabhalta, REBLOZYL, TALVEY, ENHERTU, PLUVICTO, OPDIVO.
Industry payments across LA — which companies pay providers there.
